{"schema_version":"1","generated_at":"2026-11-17T05:31:34.013Z","data_as_of":null,"url":"https://www.findmykol.com/kol/nishi-kothari","json_url":"https://www.findmykol.com/kol/nishi-kothari/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"nishi-kothari","name":"Nishi Kothari","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Nkarta Therapeutics","institution_url":"https://www.findmykol.com/institution/nkarta-therapeutics","city":"Tampa","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1790916674","openalex":"A5113870041"},"summary":"Nishi Kothari is an Oncology physician affiliated with Nkarta Therapeutics. OpenAlex indexes 44 publications with 569 citations (h-index 14).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":44,"cited_by_count":569,"h_index":14,"latest_activity_year":2024,"source":"works"},"publications":{"total":44,"shown":5,"withheld":39,"matched_by":"OpenAlex author record","recent":[{"title":"Abstract 3604: NKX101, an allogeneic off-the-shelf NKG2D CAR-NK cell therapy, has potent in vitro cytotoxicity against patient-derived AML leukemic stem cells and non-leukemic stem cell blasts","year":2024,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.am2024-3604","status":"verified"},{"title":"A Phase 1 Study of NKX101, a Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Therapy, with Fludarabine and Cytarabine in Patients with Acute Myeloid Leukemia","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2023-173582","status":"verified"},{"title":"S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES","year":2023,"journal":"HemaSphere","source_url":"https://doi.org/10.1097/01.hs9.0000967956.37234.fb","status":"verified"},{"title":"781 DELTA-2: A phase 1, open-label, multicenter study of ITIL-168, an autologous tumor-infiltrating lymphocyte (TIL) cell therapy, with pembrolizumab in patients with advanced solid tumors","year":2022,"journal":"Regular and Young Investigator Award Abstracts","source_url":"https://doi.org/10.1136/jitc-2022-sitc2022.0781","status":"verified"},{"title":"A phase III randomized, placebo-controlled, double-blind study of niraparib plus abiraterone acetate and prednisone versus abiraterone acetate and prednisone in patients with metastatic prostate cancer (MAGNITUDE).","year":2020,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.tps5588","status":"verified"}],"source":"works"},"contact":{"address_1":"12902 USF MAGNOLIA DR","city":"Tampa","state":"FL","zip":"336129416","phone":"813-745-4673","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1790916674","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":39}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2015-06-03","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}